Open access
Open access
Powered by Google Translator Translator

Cardiology

Mild COVID-19 infection is very unlikely to cause lasting heart damage

11 May, 2021 | 09:23h | UTC

Mild COVID-19 infection is very unlikely to cause lasting heart damage – Imperial College London

Original study: Prospective Case-Control Study of Cardiovascular Abnormalities 6 Months Following Mild COVID-19 in Healthcare Workers – JACC Cardiovascular Imaging

 

Commentary on Twitter

 

Observational study suggests an early head‐to‐pelvis computed tomography can expedite the diagnosis of potential causes in patients with out‐of‐hospital circulatory arrest without obvious etiology

11 May, 2021 | 09:10h | UTC

Early head‐to‐pelvis computed tomography in out‐of‐hospital circulatory arrest without obvious etiology – Academic Emergency Medicine (link to abstract – $ for full-text)

Commentary: Early Head-to-Pelvis CT for OHCA – Journal Feed

 

RCT: Artificial intelligence–enabled electrocardiograms can identify patients with low ejection fraction

11 May, 2021 | 09:00h | UTC

Artificial intelligence–enabled electrocardiograms for identification of patients with low ejection fraction: a pragmatic, randomized clinical trial – Nature Medicine

Commentaries: AI-ECG Allows for Early Diagnosis of Low EF -TCTMD AND Trial demonstrates early AI-guided detection of heart disease in routine practice – Mayo Clinic

 

M-A: Omega-3 fatty acids supplementation increases the risk of atrial fibrillation in patients with lipid disorders.

10 May, 2021 | 01:00h | UTC

Omega-3 fatty acids supplementation and risk of atrial fibrillation: an updated meta-analysis of randomized controlled trials – European Heart Journal – Cardiovascular Pharmacotherapy

Commentaries: Fish oil supplements linked with heart rhythm disorder – European Society of Cardiology AND Could High-Dose Fish Oil Raise Odds for A-Fib in Heart Patients? – HealthDay

 

Commentary on Twitter

 

[#ACC21 – not published yet] 1 in 5 adults with high blood pressure also take a medicine that could be elevating their blood pressure.

10 May, 2021 | 00:58h | UTC

Have high blood pressure? You may want to check your meds – American College of Cardiology

Commentary: Are You Taking a Med That’s Raising Your Blood Pressure? – HealthDay

 

Review: Colchicine and the heart.

10 May, 2021 | 00:56h | UTC

Colchicine and the heart – European Heart Journal

Related meta-analysis: Colchicine administration for percutaneous coronary intervention

Related randomized trials: Colchicine in patients with chronic coronary disease (study and commentaries) AND Low-Dose Colchicine Improves Outcomes after Myocardial Infarction (study and commentaries) AND Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT) (study and commentary)

 

Commentary on Twitter

 

Short review: How to diagnose and manage QT prolongation in cancer patients

7 May, 2021 | 08:18h | UTC

How to Diagnose and Manage QT Prolongation in Cancer Patients – JACC: CardioOncology

 

Commentary on Twitter (thread – click for more)

 

Review: Diagnosis and management of stable angina.

6 May, 2021 | 08:49h | UTC

Diagnosis and Management of Stable Angina: A Review – JAMA (free for a limited period)

Podcast: Chronic Stable Angina—Diagnosis and Treatment – JAMA

 

USPSTF Draft Statement: Insufficient evidence to recommend multivitamin supplements for the prevention of CVD or cancer. The statement also recommends against the use of beta-carotene (increases risk of CVD mortality and lung cancer) or vitamin E (clear evidence of no benefit)

5 May, 2021 | 08:30h | UTC

Draft Recommendation Statement: Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer – U.S. Preventive Services Task Force

Draft Evidence Review: Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer

 

Management of the Patient With Patent Foramen Ovale in 2021: A Spectrum of Cases

5 May, 2021 | 08:15h | UTC

Management of the Patient With Patent Foramen Ovale in 2021: A Spectrum of Cases – Mayo Clinic Proceedings

 

ISCHEMIA trial – days alive out of hospital endpoint was higher in the conservative management group vs. invasive management group at 1 month (30.8 vs 28.4 days), 1 year (362.2 vs 355.9 days), and 2 years (718.4 vs 712.1 days)

4 May, 2021 | 08:41h | UTC

Comparison of Days Alive Out of Hospital With Initial Invasive vs Conservative Management: A Prespecified Analysis of the ISCHEMIA Trial – JAMA Cardiology (free for a limited period)

Original study: ISCHEMIA Trial: Health-Status Outcomes with Initial Invasive vs. Conservative Care in Stable Coronary Disease AND ISCHEMIA Trial: Initial Invasive vs. Conservative Strategy for Stable Coronary Disease AND ISCHEMIA Trial: Health Status after Invasive or Conservative Care in Coronary and Advanced Kidney Disease AND ISCHEMIA Trial: Management of Coronary Disease in Patients with Advanced Kidney Disease

 

M-A: In patients with atrial fibrillation, catheter ablation was associated with a 38% reduction in recurrence and a 68% reduction in hospitalizations. The rate of serious complications was 4.2% with ablation vs. 2.8% in the antiarrhythmic group, a difference that was not statistically significant.

4 May, 2021 | 08:39h | UTC

Assessment of Catheter Ablation or Antiarrhythmic Drugs for First-line Therapy of Atrial Fibrillation: A Meta-analysis of Randomized Clinical Trials – JAMA Cardiology (free for a limited period)

Commentary: Catheter ablation tops medication alone for treating AFib—but the risk of complications remains – Cardiovascular Business

 

Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation

4 May, 2021 | 08:38h | UTC

2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation – EP Europace

Commentary: EHRA Updates Its Popular ‘Practical’ NOAC Guide – TCTMD

 

Study: A high dietary sodium intake in patients with postural tachycardia syndrome reduces upright heart rate, increases plasma volume, lowers standing plasma norepinephrine, and decreases variability in heart rate

4 May, 2021 | 08:32h | UTC

Effect of High Dietary Sodium Intake in Patients With Postural Tachycardia Syndrome – Journal of the American College of Cardiology (link to abstract – $ for full-text)

Commentary: High Salt Intake Benefits Patients with Postural Tachycardia Syndrome – Medical Dialogues AND Effect of High Dietary Sodium Intake in POTS Patients – American College of Cardiology

 

Commentary on Twitter

 

M-A: Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease – “a 5 mm Hg reduction of systolic BP reduced the risk of major CV events by about 10%, irrespective of previous diagnoses of CV disease, and even at normal or high–normal BP values”

3 May, 2021 | 05:29h | UTC

Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis – The Lancet

Commentaries: Many more people could benefit from blood pressure-lowering medication – The Lancet AND Decisions about antihypertensive treatment should focus on reducing cardiovascular risk – The Lancet

 

Study: Patients with heart failure have a much higher incidence of pneumonia than matched individuals in the population. The development of pneumonia in these patients is associated with a 3- to 4-fold higher risk of cardiovascular and all-cause death.

3 May, 2021 | 05:18h | UTC

Incidence and Outcomes of Pneumonia in Patients With Heart Failure – Journal of the American College of Cardiology

Commentaries: Pneumonia in HF Patients Is Common, Lethal, and Preventable – TCTMD AND Outcomes of Pneumonia in Patients With Heart Failure – American College of Cardiology

 

AHA Statement: Management of Stage 1 Hypertension in Adults With a Low 10-Year Risk for Cardiovascular Disease – “There is a lack of randomized clinical trials that have evaluated CVD outcomes among individuals with stage 1 hypertension and a low 10-year ASCVD risk”

30 Apr, 2021 | 08:37h | UTC

Management of Stage 1 Hypertension in Adults With a Low 10-Year Risk for Cardiovascular Disease: Filling a Guidance Gap: A Scientific Statement From the American Heart Association – Hypertension

News Release: If slightly high blood pressure doesn’t respond to lifestyle change, medication can help – American Heart Association

Top Things to Know: Management of Stage 1 Hypertension in Adults With a Low 10-Year Risk for Cardiovascular Disease – American Heart Association

Commentary: The Hypertension Pandemic: Need for a Strategic Evidence-based Response – American Heart Association

 

AHA Statement: Prevention of Viridans Group Streptococcal Infective Endocarditis – Antibiotic prophylaxis for invasive dental procedures is suggested only for high-risk patients with the following conditions: 1) cardiac prosthetic valve; 2) previous infective endocarditis; 3) congenital heart disease; or 4) previous heart transplant

30 Apr, 2021 | 08:35h | UTC

Prevention of Viridans Group Streptococcal Infective Endocarditis: A Scientific Statement From the American Heart Association

News release: Good dental health may help prevent heart infection from mouth bacteria – American Heart Association

Top Things to Know: Prevention of Viridans Group Streptococcal Infective Endocarditis – American Heart Association

Slide set: Prevention of Viridans Group Streptococcal Infective Endocarditis

Commentaries: Commentary for Prevention of Viridans Group Streptococcal Infective Endocarditis – American Heart Association

 

Commentary on Twitter (thread – click for more)

 

AHA Scientific Statement: Close monitoring for heart risk needed if breast, prostate cancer treatment includes hormonal therapies

29 Apr, 2021 | 08:33h | UTC

Impact of Hormonal Therapies for Treatment of Hormone-Dependent Cancers (Breast and Prostate) on the Cardiovascular System: Effects and Modifications: A Scientific Statement From the American Heart Association – Circulation: Genomic and Precision Medicine

News release: Close monitoring for heart risk needed if breast, prostate cancer treatment includes hormones – American Heart Association

Top Things to Know: Impact of Hormonal Therapies for Treatment of Hormone-Dependent Cancers (Breast and Prostate) on the Cardiovascular System – American Heart Association

Commentaries: Hormonal Therapy for Breast and Prostate Cancer: Lessons and Opportunities – American Heart Association AND Hormonal Based Therapies in the Treatment of Breast and Prostate Cancer – balancing the risks! – American Heart Association AND Hormone Cancer Therapies Increase CV Risk: AHA Scientific Statement – TCTMD AND Closely Monitor Heart Health in Cancer Patients Who Get Hormonal Therapies: AHA – HealthDay

 

USPSTF Statement recommends screening for hypertension in adults 18 years or older with office blood pressure measurement – diagnostic confirmation with blood pressure measurements outside of the clinical setting is advised before starting treatment

28 Apr, 2021 | 08:16h | UTC

Evidence Report: Screening for Hypertension in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force – JAMA

Author Interview: USPSTF Recommendation: Screening for Hypertension in Adults

Editorials: The USPSTF Recommendation on Blood Pressure Screening: Making 2021 the Transformative Year in Controlling Hypertension AND USPSTF Recommendation Statement on Hypertension Screening in Adults—Where Do We Go From Here? – JAMA Network Open AND Will the 2021 USPSTF Hypertension Screening Recommendation Decrease or Worsen Racial/Ethnic Disparities in Blood Pressure Control? – JAMA Network Open AND USPSTF Recommendations for Screening for Hypertension in Adults: It Is Time to Unmask Hypertensive Risk – JAMA Cardiology

JAMA Patient Page: Screening for Hypertension in Adults

 

NICE publishes updated clinical guideline on the diagnosis and management of atrial fibrillation

27 Apr, 2021 | 09:33h | UTC

Guideline: Atrial fibrillation: diagnosis and management – National Institute for Health and Care Excellence

News release: NICE publishes updated clinical guideline on the diagnosis and management of atrial fibrillation – National Institute for Health and Care Excellence

 

RCT: Reduced dose direct oral anticoagulants may be a safer option to vitamin K antagonists in hemodialysis patients with atrial fibrillation

27 Apr, 2021 | 09:27h | UTC

Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multicenter Randomized Controlled Trial – Journal of the American Society of Nephrology (link to abstract – $ for full-text)

 

Commentary on Twitter

 

Long Covid: Largest post-acute COVID-19 study to date examined the health outcomes in more than 73,000 people who’d had COVID-19 and were not hospitalized

23 Apr, 2021 | 08:48h | UTC

High-dimensional characterization of post-acute sequalae of COVID-19 – Nature

Commentary: Among COVID-19 survivors, an increased risk of death, serious illness – Washington University School of Medicine

 

Commentary on Twitter (thread – click for more)

 

AHA Scientific Statement: Obesity and Cardiovascular Disease

23 Apr, 2021 | 08:22h | UTC

Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association – Circulation

News Release: More belly weight increases danger of heart disease even if BMI does not indicate obesity – American Heart Association

Commentary: It’s time to measure your waistline, according to new recommendations. Belly fat raises your risk for disease – CNN

 

Long-Term Cardiovascular Outcomes in Systemic Lupus Erythematosus

23 Apr, 2021 | 08:08h | UTC

Cardiovascular Outcomes in Systemic Lupus Erythematosus – American College of Cardiology

Original study: Long-Term Cardiovascular Outcomes in Systemic Lupus Erythematosus – Journal of the American College of Cardiology (link to abstract – $ for full-text)

 

Stay Updated in Your Specialty

No spam, just news.